Disease progression in cancer is dependent on the complex interaction between the tumor
and the host inflammatory response. There is substantial evidence in advanced cancer that …

A chronic systemic inflammatory response is clearly implicated in the progressive nutritional
and functional decline in the cancer patients and their subsequent poor outcome. Systemic …

Purpose A systematic literature review was done to determine the relationship between
elevated CRP and prognosis in people with solid tumors. C-reactive protein (CRP) is a …

Progressive involuntary weight loss, in particular the loss of lean tissue, is common in
patients with advanced cancer and has long been recognised to result in a deterioration in …

CONTEXT: The natural history of renal cell carcinoma (RCC) is highly unpredictable. Small
renal masses may be accompanied by metastatic disease. Conversely, patients with locally …

The outcome of tumors results from genetic and epigenetic modifications of the transformed
cells and also from the interactions of the malignant cells with their tumor microenvironment …

Background The C-reactive protein/albumin (CRP/Alb) ratio is associated with outcome in
septic patients. However, as an inflammation-based score, its prognostic value for cancer …

The link between chronic inflammation and increased risk of developing some cancers is
well established. The molecular mechanisms that underlie this process (cause) as well as …

Background: Recent evidence indicates that the host inflammatory response has an
important role in the tumour progression. Elevated C-reactive protein (CRP) levels have …

BACKGROUND: The benefits of cytoreductive nephrectomy (CN) in metastatic renal cell
carcinoma (mRCC) should outweigh surgical morbidity. Even when the generally agreed …